EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS

Nataša Đorđević, Sonja Zafirović, Jelena Radovanović, Julijana Stanimirović, Nikola Ninković, Zoran Gluvić, Aleksandra Klisić, Esma R. Isenović

Taurunum Medical Journal · 31.05.2026 · 40 (1)

DOI: 10.63696/tmj202601003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Taurunum Medical Journal, online erschienen am 31.05.2026. Verfasst von Nataša Đorđević und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

<p><strong>Introduction:</strong>&nbsp;Type 2 diabetes mellitus (T2DM) is linked to increased&nbsp;vascular&nbsp;morbidity and mortality. Well-controlled diabetes is indicated&nbsp;by&nbsp;effective&nbsp;glycemic and HbA1c regulation and low-grade inflammation management.&nbsp;This&nbsp;study&nbsp;evaluates&nbsp;glycolipid&nbsp;control and inflammatory status in T2DM patients on metformin.</p> <p><strong>Methods</strong><strong>: </strong>A pilot study&nbsp;involved 11 participants&nbsp;divided&nbsp;into&nbsp;two&nbsp;groups: a T2DM group on metformin therapy and a control, non-diabetic&nbsp;group. Demographic, clinical, anthropometric, glycolipid (glycemia, HbA1c, TC, LDL-C, HDL-C, TG), and inflammatory&nbsp;parameters (CRP, FFA, PL, UA, FLI) were&nbsp;evaluated.</p> <p><strong>Results</strong><strong>:</strong>&nbsp;Significant&nbsp;intergroup&nbsp;differences&nbsp;were&nbsp;found in glycemia, HbA1c, TC, LDL-C, UA, FLI, and WC. Glycemia&nbsp;influenced PL (p&lt;0.05), UA (p&lt;0.01), and FLI (p&lt;0.01), while HbA1c affected UA (p&lt;0.05) and FLI (p&lt;0.01). LDL-C and HDL-C impacted UA (p&lt;0.05, p&lt;0.01). Age affected FLI (p&lt;0.05), gender&nbsp;influenced PL (p&lt;0.01), and BW, BH, WC, and BMI significantly&nbsp;impacted UA and FLI (p&lt;0.01).</p> <p><strong>Conclusion</strong><strong>:</strong>&nbsp;T2DM patients&nbsp;showed&nbsp;signs of low-grade systemic&nbsp;inflammation, emphasizing&nbsp;the&nbsp;need&nbsp;for&nbsp;comprehensive diabetes management and early&nbsp;cardiovascular&nbsp;risk&nbsp;detection. Intensified&nbsp;interventions are necessary&nbsp;for&nbsp;patients&nbsp;with&nbsp;inadequate&nbsp;glycemic&nbsp;control on metformin.</p>

Zitieren

APA

Đorđević, N., Zafirović, S., Radovanović, J., Stanimirović, J., Ninković, N., Gluvić, Z., Klisić, A., & Isenović, E. R. (2026). GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS. Taurunum Medical Journal, 40(1). https://doi.org/10.63696/tmj202601003

Vancouver

Đorđević N, Zafirović S, Radovanović J, Stanimirović J, Ninković N, Gluvić Z, et al. GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS. Taurunum Medical Journal. 2026;40(1). doi:10.63696/tmj202601003

BibTeX
@article{orevi2026,
  author = {Đorđević, Nataša and Zafirović, Sonja and Radovanović, Jelena and Stanimirović, Julijana and Ninković, Nikola and Gluvić, Zoran and Klisić, Aleksandra and Isenović, Esma R.},
  title = {GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS},
  journal = {Taurunum Medical Journal},
  year = {2026},
  volume = {40},
  number = {1},
  doi = {10.63696/tmj202601003}
}
Kostenlos starten →